NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
05/27/2025
Back to search
Official data from USPTO
CIMBAN
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
15
Latest update
05/27/2025
Trademark type
Word
Nice classes
1, 42
Filing date
05/20/2024
Registration date
05/27/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/27/2025
Last transaction
05/27/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Foreign priority
Drawing code
4
Owner type
16
Owner location
SAFFRON WALDEN, Essex, GB
Examiner
TAYLOR, SLOAN H
Law office
O20
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
Camena Bioscience Limited
Representatives
Jeffrey H. Greene Foley & Lardner LLP
Technical classification
Nice Classes
Class 1Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Chemicals for use in the biochemical and chemical industry; Chemical substances for use in the production of drugspharmaceuticals and antibodies; Active chemical ingredients for use in the production of drugspharmaceuticals and antibodies; DNA nucleotidesRNA nucleotidesXNA nucleotidesbiotechnologically formed genesoligonucleotides and proteins for scientific and research use; Nucleic acids comprising synthetic nucleotides for scientific and research use; Synthetic DNA nucleotidessynthetic RNA nucleotidessynthetic genes being biotechnologically formed genessynthetic oligonucleotides and synthetic proteins for laboratoryscientific and industrial use; Chemical preparationssynthetic enzymesgene editing enzymesDNA nucleotidesRNA nucleotidesXNA nucleotidesbiotechnologically formed genesoligonucleotides and proteins for laboratoryscientific and industrial purposes; Synthetic DNA and RNA nucleotides for scientific and medical research; synthetic DNA nucleotidesRNA nucleotidesXNA nucleotidesbiotechnologically formed genesoligonucleotides and proteins for use in medical biologics and therapeutics; Molecular biology research tools in the nature of chemicalbiological and biochemical reagents used for the synthesis of DNARNAXNAoligonucleotidesgenes and proteins.
Class 42
Consultancy in relation to biochemistry and biotechnology; Research and development in the field of biotechnology and synthetic biology; Biological analysis; Biotechnological research relating to enzymatic synthesis; Provision of gene synthesis solutionscreating and modifying genetic sequences for scientific purposes; Development and test of enzyme production methods; Evaluationsestimatesresearch and preparing related reports and technical documentation of genetic materials all in the field of enzymatic production; Scientific and technological services in the field of biotechnology consisting of the development of innovative processes to produce synthetic genes; Genetic engineeringproduction of nucleic acid sequences; Research and development services relating to the creation of synthetic nucleic acid sequences; Genetic engineering services being the designdevelopmenttesting of synthetic gene sequences; Designdevelopmentrental and leasing of test and collection devices and kits for analysis of nucleic acid sequencesnucleic acids and genetic materials; Genetic engineering servicesmanufacture of synthetic DNARNAgenes and oligonucleotides for others; Genetic engineering and scientific laboratory services being the designdevelopment and testing of synthetic gene sequences in complex gene production; Research and development services in the field of nucleic acid synthesis technology; Technical consulting in the field of biotechnology; Genetic engineeringproduction of complex gene sequences; Consultancyadvisory and information services related to the aforementioned services; Software-as-a-Service (SaaS) services featuring software with a bioinformatics algorithm for use in designing gene assembly paths; Platform-as-a Service (PaaS) services featuring software platforms with a bioinformatics algorithm for use in designing gene assembly paths.
Publications
History of USPTO decisions and trademark events.
15 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
05/27/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/08/2025
PUBO
PUBLISHED FOR OPPOSITION
04/08/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/02/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/13/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/06/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/06/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/06/2025
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
12/18/2024
GNRT
NON-FINAL ACTION E-MAILED
12/18/2024
CNRT
NON-FINAL ACTION WRITTEN
12/18/2024
DOCK
ASSIGNED TO EXAMINER
12/04/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11/22/2024
NWAP
NEW APPLICATION ENTERED
05/20/2024
Continuous trademark protection
Get notified about every new filing that threatens CIMBAN or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.